Together, our study demonstrates a signaling axis involving STAT3/FGF7/AKT that mediates the crosstalk between CAFs and ccRCC tumor cells (Figure 6D), providing valuable insights for treating ccRCC patients. This evidence concerns the gene STAT3 and nonpapillary renal cell carcinoma.